For instance, several quinazoline-based compounds have been developed as epidermal growth factor receptor (EGFR) inhibitors for treating cancers, particularly non-small lung cancer cells, by impeding tumor growth and proliferation [12,13,14,15]. This evidence concerns the gene EGFR and neoplasm.